Drug for treating skin scars
A scar and drug technology, applied in the field of drugs for treating skin scars, can solve problems such as side effects and adverse reactions, and achieve the effects of obvious effects, convenient use and low drug prices.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] Embodiment 1: A medicine for treating skin scars, which is composed of the following raw materials in parts by weight: 495 grams of rhubarb, 245 grams of turmeric, 295 grams of bellflower, 195 grams of frankincense, and 195 grams of myrrh. Mix the above-mentioned medicines in proportion to make powder, 60 grams at a time, wrap it in cotton cloth and decoct for 5 minutes, and apply it to the scar, then warm the medicine, apply it repeatedly for one hour, twice a day. The medicine prepared in this embodiment also adopts the above-mentioned diagnosis basis, curative effect evaluation and treatment method to carry out clinical trials. 3012 patients were treated, and the treatment results: 2530 cases were cured, accounting for 84%, 331 cases were improved, accounting for 11%, and 151 cases were not cured, accounting for 5%.
Embodiment 2
[0024] Embodiment 2: A medicine for treating skin scars, which is composed of the following raw materials in parts by weight: 500 grams of rhubarb, 250 grams of turmeric, 300 grams of bellflower, 200 grams of frankincense, and 200 grams of myrrh. The method for preparing and using the medicine is the same as in Example 1.
Embodiment 3
[0025] Embodiment 3: A medicine for treating skin scars, which is composed of the following raw materials in parts by weight: 505 grams of rhubarb, 255 grams of turmeric, 305 grams of bellflower, 205 grams of frankincense, and 205 grams of myrrh. The method for preparing and using the medicine is the same as in Example 1. The medicine prepared in this embodiment also adopts the above-mentioned diagnosis basis, curative effect evaluation and treatment method to carry out clinical trials. 3115 patients were treated, and the treatment results: 2585 cases were cured, accounting for 83%, 405 cases were improved, accounting for 13%, and 125 cases were not cured, accounting for 4%.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More